Find clinical trials for Colon Cancer in San Diego, CA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Colorectal Cancer
Colonic Cancer
Neoplasm Metastasis
Lung Cancer
Non-Small-Cell Lung Carcinoma

Colon Cancer trials near San Diego, CA, USA:

Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer (AZUR-2)

(SOC) in participants with untreated T4N0 or Stage III (resectable), defective mismatch repair/ microsatellite instability high (dMMR/MSI-H) colon...

Colonic Neoplasms
Neoplasms, Colon
Biological: Dostarlimab

Phase 3

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

Tijuana, Baja California, Mexico and 212 other locations

to participants with advanced solid tumors, including rearranged during transfection (RET)-fusion-positive solid tumors, medullary thyroid cancer...

Colon Cancer
Medullary Thyroid Cancer
Drug: LOXO-292

Phase 1, Phase 2

Loxo Oncology
Loxo Oncology

La Jolla, California, United States and 83 other locations

the what kind of chemotherapy to recommend to patients based on the presence or absences of circulating tumor DNA (ctDNA) after surgery for colon...

Stage III Colon Cancer
Drug: mFOLFOX6 3-6 month
Device: Signatera test

Phase 2, Phase 3

NRG Oncology

San Diego, California, United States and 831 other locations

This is a first-in-human, open-label, non-randomized, three-part phase 1 trial of INBRX-109, which is a recombinant humanized tetravalent antibody ta...

Malignant Pleural Mesothelioma
Colorectal Adenocarcinoma
Drug: 5-fluorouracil
Drug: Irinotecan

Phase 1


San Diego, California, United States and 18 other locations

clinical trial to evaluate the safety, tolerability, and PK of fruquintinib in patients with advanced solid tumors, metastatic colorectal cancer...

Active, not recruiting
Metastatic Breast Cancer
HER2-negative Breast Cancer
Drug: Fruquintinib (HMPL-013)

Phase 1


San Marcos, California, United States and 8 other locations

A Phase 1 dose escalation study in patients with advanced solid tumors harboring KRAS G12C mutation to determine the maximum tolerated dose and recom...

Cancer of Pancreas
Colon Cancer
Drug: HBI-2438

Phase 1


Encinitas, California, United States and 13 other locations

This is a Phase 1/2, first-in-human, open-label, dose escalation and dose-expansion study of E-602, administered alone and in combination with cemipl...

Breast Cancer
Colon Cancer
Biological: Cemiplimab
Biological: E-602

Phase 1, Phase 2

Palleon Pharmaceuticals

La Jolla, California, United States and 12 other locations

This study will evaluate the safety, tolerability, drug levels, molecular effects, and clinical activity of MRTX849 (adagrasib) in patients with adva...

Metastatic Cancer
Advanced Cancer
Drug: MRTX849
Drug: Afatinib

Phase 1, Phase 2

Mirati Therapeutics
Mirati Therapeutics

San Diego, California, United States and 97 other locations

with either (a) hepatocellular carcinoma (HCC) that is not amenable to resection, transplant or other potentially curative therapy or (b) cancer...

Active, not recruiting
Metastatic Colorectal Cancer
Metastatic Pancreatic Cancer
Drug: PV-10 (10% rose bengal disodium)

Phase 1

Provectus Biopharmaceuticals

San Diego, California, United States and 4 other locations

Recently updated

The purpose of the study is to determine whether plinabulin (also known as BPI-2358) has an effect on cancer and body in combination with ni...

Active, not recruiting
Non-small Cell Lung Cancer Metastatic
Drug: Nivolumab + Plinabulin

Phase 1

Lyudmila Bazhenova, M.D.

La Jolla, California, United States

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems